OBMP Projected Dividend Yield
OncBioMune Pharmaceuticals Inc ( OTCBB : OBMP )OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the development of cancer immunotherapy products, with a proprietary vaccine technology that is designed to stimulate the immune system to attack its own cancer while not attacking the patient's cells. Co. has proprietary rights to an investigational immunotherapy platform with an initial focus on prostate and breast cancers but that may be used to fight any solid tumor. Co. is also developing targeted therapies. Co.'s primary product, ProscaVax™, is an immunotherapy product from its platform. 20 YEAR PERFORMANCE RESULTS |
OBMP Dividend History Detail OBMP Dividend News OBMP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |